Cargando…

Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts

PURPOSE: There is a need for adjuvant/neo-adjuvant treatment strategies to prevent metastatic relapse in soft tissue sarcoma (STS). Tumor hypoxia is associated with a high-risk of metastasis and is potentially targetable. This study aimed to derive and validate a hypoxia mRNA signature for STS for f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Lingjian, Forker, Laura, Irlam, Joely J., Pillay, Nischalan, Choudhury, Ananya, West, Catharine M. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790513/ https://www.ncbi.nlm.nih.gov/pubmed/29423096 http://dx.doi.org/10.18632/oncotarget.23280

Ejemplares similares

Correction: Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts
por: Yang, Lingjian, et al.
Publicado: (2019)

Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma
por: Forker, Laura J., et al.
Publicado: (2023)

The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma
por: Forker, Laura, et al.
Publicado: (2018)

Development and validation of a hypoxia-associated signature for lung adenocarcinoma
por: Lane, Brian, et al.
Publicado: (2022)

A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer
por: Khan, Mairah T., et al.
Publicado: (2021)

Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial()
por: Eustace, Amanda, et al.
Publicado: (2013)

Selection of endogenous control genes for normalising gene expression data derived from formalin-fixed paraffin-embedded tumour tissue
por: Smith, Tim A. D., et al.
Publicado: (2020)

DNA methylation‐based profiling of bone and soft tissue tumours: a validation study of the ‘DKFZ Sarcoma Classifier’
por: Lyskjær, Iben, et al.
Publicado: (2021)

Feasibility of a multiparametric MRI protocol for imaging biomarkers associated with neoadjuvant radiotherapy for soft tissue sarcoma
por: Kershaw, Lucy, et al.
Publicado: (2021)

The treatment of periarticular soft tissue sarcoma following neo-adjuvant radiotherapy: a cohort study
por: Green, Carl M, et al.
Publicado: (2015)

Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma
por: Shen, Rui, et al.
Publicado: (2021)

Does magnetic resonance imaging improve soft tissue sarcoma contouring for radiotherapy?
por: Vickers, Alexander John, et al.
Publicado: (2019)

Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer
por: Yang, Lingjian, et al.
Publicado: (2018)

The effect of hypoxia on PD-L1 expression in bladder cancer
por: Smith, Vicky, et al.
Publicado: (2021)

Survival-associated alternative splicing signatures in soft tissue sarcomas
por: Ren, Xianghai, et al.
Publicado: (2020)

Identification and Validation of a Novel Pyroptosis-Related Gene Signature for Prognosis Prediction in Soft Tissue Sarcoma
por: Qi, Lin, et al.
Publicado: (2021)

Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential
por: Francis, Princy, et al.
Publicado: (2007)

Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature
por: Bertucci, Francois, et al.
Publicado: (2022)

Development of a radiosensitivity gene signature for patients with soft tissue sarcoma
por: Tang, Zaixiang, et al.
Publicado: (2017)

Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018)

An overview of mutational and copy number signatures in human cancer
por: Steele, Christopher D, et al.
Publicado: (2022)

Identification and Validation of Pyroptosis-Related lncRNA Signature and Its Correlation with Immune Landscape in Soft Tissue Sarcomas
por: Lin, Zhengjun, et al.
Publicado: (2021)

Multiple Flap Transfer for Multiple Local Recurrence of Soft Tissue Sarcoma
por: Karakawa, Ryo, et al.
Publicado: (2023)

Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer
por: Irlam-Jones, J J, et al.
Publicado: (2016)

Retroperitoneal soft tissue sarcoma
por: Zepeda, Ernesto, et al.
Publicado: (2007)

Trabectedin in Soft Tissue Sarcomas
por: Petek, Bradley J., et al.
Publicado: (2015)

Soft Tissue Sarcomas of the Kidney
por: Köhle, Olivia, et al.
Publicado: (2015)

Bone and Soft Tissue Sarcoma
por: Ruggiero, Antonio
Publicado: (2020)

Trabectedin for soft tissue sarcoma
Publicado: (2021)

Establishing an RNA fusions panel in soft tissue sarcoma with clinical validation
por: Huang, Xiaoqiang, et al.
Publicado: (2023)

Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations
por: Nordsmark, M, et al.
Publicado: (2001)

Hypoxia-Inducible Factors: Mediators of Cancer Progression; Prognostic and Therapeutic Targets in Soft Tissue Sarcomas
por: Sadri, Navid, et al.
Publicado: (2013)

A prognostic profile of hypoxia-induced genes for localised high-grade soft tissue sarcoma
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2016)

Predicting radiotherapy response for patients with soft tissue sarcoma by developing a molecular signature
por: Tang, Zaixiang, et al.
Publicado: (2017)

A novel inflammatory signature for evaluating immune microenvironment status in soft tissue sarcoma
por: Li, Zhehong, et al.
Publicado: (2022)

New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
por: Seong, Gyuhee, et al.
Publicado: (2023)

Development and validation of an RNA sequencing panel for gene fusions in soft tissue sarcoma
por: Hu, Wanming, et al.
Publicado: (2022)

Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer
por: Hunter, B A, et al.
Publicado: (2014)

Delays in Referral of Soft Tissue Sarcomas
por: Johnson, G. D., et al.
Publicado: (2008)

Paediatric bone and soft tissue sarcoma
por: Anderson, J
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_3t2e3vdqafteh3n6fuljtuq3ch